biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
22:17 Gene therapy improved swallowing in all 9 patients so far, maker says✦22:16 Taurine helps keep aging inflammation in check in lab tests, study finds✦22:13 Boosting one protein left old mice less frail and living 14% longer✦22:13 Adding a drug to Keytruda halved death risk in a head and neck cancer trial✦22:10 US lets pharmacies make 6 unapproved peptides for now, despite FDA doubts✦16:30 Older adults who nap most days had a 48% higher dementia risk, study finds✦16:28 Study ties weaker muscles in old age to faulty nerve-to-muscle signals✦16:23 Lilly says experimental shot beat Ozempic with over double the weight loss✦22:17 Gene therapy improved swallowing in all 9 patients so far, maker says✦22:16 Taurine helps keep aging inflammation in check in lab tests, study finds✦22:13 Boosting one protein left old mice less frail and living 14% longer✦22:13 Adding a drug to Keytruda halved death risk in a head and neck cancer trial✦22:10 US lets pharmacies make 6 unapproved peptides for now, despite FDA doubts✦16:30 Older adults who nap most days had a 48% higher dementia risk, study finds✦16:28 Study ties weaker muscles in old age to faulty nerve-to-muscle signals✦16:23 Lilly says experimental shot beat Ozempic with over double the weight loss
← All story threadsSTORY THREAD

Pill to help brain cells clear worn-out parts in Parkinson's.

1 report so far. New developments are added to this thread as they happen.

  1. Oct 15, 2026
    FIRST PATIENT TREATED IN A 36-PERSON TRIALTrial start · 36 patients

    First Parkinson's patient gets a pill meant to clear cells' worn-out parts

    A UK biotech has treated the first of 36 people with Parkinson's in a trial of a pill designed to help brain cells remove their damaged power plants. First results are expected in late 2027.